Skip to content


BMC Medical Genomics

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Association of differential gene expression with imatinib mesylate and omacetaxine mepesuccinate toxicity in lymphoblastoid cell lines

  • Hemant Kulkarni1Email author,
  • Harald H H Göring1,
  • Vincent Diego1,
  • Shelley Cole1,
  • Ken R Walder2,
  • Greg R Collier3,
  • John Blangero1 and
  • Melanie A Carless1Email author
BMC Medical Genomics20125:37

Received: 22 March 2012

Accepted: 16 August 2012

Published: 23 August 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
22 Mar 2012 Submitted Original manuscript
16 Apr 2012 Reviewed Reviewer Report - Esther Black
22 May 2012 Reviewed Reviewer Report - Patrice Morin
25 Jul 2012 Author responded Author comments - Hemant Kulkarni
Resubmission - Version 2
25 Jul 2012 Submitted Manuscript version 2
16 Aug 2012 Editorially accepted
23 Aug 2012 Article published 10.1186/1755-8794-5-37

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Department of Genetics, Texas Biomedical Research Institute
Deakin University
Barwon Biotechnology